/news-releases/news-release-details/moderna-announces-progress-prophylactic-vaccines-modality-cmv  ::  Moderna Announces Progress in Prophylactic Vaccines Modality with CMV Vaccine Phase 2 Study Data Now Expected in Third Quarter 2020 and Expands Investment in This Core Modality with Three New Development Candidates